Ardelyx, Inc. (ARDX): Price and Financial Metrics
Ardelyx, Inc. (ARDX)
Today's Latest Price: $7.00 USD
0.15 (-2.10%)
Updated Dec 13 6:55pm
Add ARDX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
ARDX Stock Summary
- Ardelyx Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than only 7.4% of US listed stocks.
- ARDX's price/sales ratio is 1,219.48; that's higher than the P/S ratio of 99.7% of US stocks.
- As for revenue growth, note that ARDX's revenue has grown -99.38% over the past 12 months; that beats the revenue growth of merely 0.49% of US companies in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to Ardelyx Inc are PSTI, AUPH, RARX, RVNC, and NK.
- ARDX's SEC filings can be seen here. And to visit Ardelyx Inc's official web site, go to www.ardelyx.com.
ARDX Daily Price Range
ARDX 52-Week Price Range
ARDX Stock Price Chart More Charts
ARDX Price/Volume Stats
| Current price | $7.00 | 52-week high | $8.31 |
| Prev. close | $7.15 | 52-week low | $1.60 |
| Day low | $6.84 | Volume | 689,500 |
| Day high | $7.16 | Avg. volume | 543,217 |
| 50-day MA | $5.79 | Dividend yield | N/A |
| 200-day MA | $3.89 | Market Cap | 460.61M |
Ardelyx, Inc. (ARDX) Company Bio
Ardelyx is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative, minimally-systemic, small molecule therapeutics that work exclusively in the gastrointestinal tract to treat cardio-renal, gastrointestinal and metabolic diseases. The company was founded in 2007 and is based in Fremont, California.
Top Stories View All
3 “Must Own” Online Growth Stocks
Best & Worst Performing Stock Industries for December 13, 2019
Best & Worst Performing Small Cap Stocks for December 13, 2019
Best & Worst Performing Mid Cap Stocks for December 13, 2019
Best & Worst Performing Large Cap Stocks for December 13, 2019
View All Top Stories
Loading social stream, please wait...